Botulism; Poisoning

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Botulism; Poisoning trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05990881

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb jo…

United States50 participantsStarted 2023-08-27

Treatment: Botulinum toxin, Standard-of-care corticosteroid injections

All recent trials (19 shown)

By InvitationPhase 4

NCT02051062

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients

The purpose of this study is to verify the pediatric dosing recommendations for BAT product in pediatric patients that are treated with BAT product due to a con…

Location not specified10 participantsStarted 2014-10

Treatment: Blood sample collection

CompletedPhase 2/3

NCT01441557

Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

Main objectives: Evaluate the effectiveness of an administration of 3,4-diaminopyridine (FIRDAPSE ®) in severe botulinic poisoning in measuring the effect on e…

France3 participantsStarted 2011-09

Treatment: 3,4-diaminopyridine

Botulism; Poisoning

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

All recent trials (19 shown)

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients

Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

All recent trials (19 shown)

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients

Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®

Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA

Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects

Study of the Drug B11-FC (Botulism Treatment)

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults

Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®

Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients

Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

Retrospective Epidemiological Study on Botulism in Intensive Care Units in France

Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunte…

Study of Human Botulism Immunoglobulin in Infants With Botulism

Phase 1 PK Study of XOMA 3AB

Treatment of Survivors After Botulism Outbreak

Botulism Outbreak in Thailand (Episode II)